Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE).
Journal: Oncoimmunology
Published: November 27, 2018
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
Journal: Cancer research
Published: February 09, 2013
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.
Journal: Nature medicine
Published: January 14, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026